Page last updated: 2024-10-28

gyki 52466 and Substance-Related Disorders

gyki 52466 has been researched along with Substance-Related Disorders in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Substance-Related Disorders: Disorders related to substance use or abuse.

Research Excerpts

ExcerptRelevanceReference
" Mice withdrawn from chronic treatment with diazepam showed a time-related evolution of anxiety, muscle rigidity, and seizures between days 4 and 21 after treatment discontinuation."3.68Diazepam dependence prevented by glutamate antagonists. ( Steppuhn, KG; Turski, L, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steppuhn, KG1
Turski, L1

Other Studies

1 other study available for gyki 52466 and Substance-Related Disorders

ArticleYear
Diazepam dependence prevented by glutamate antagonists.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Jul-15, Volume: 90, Issue:14

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Drug Tolerance; Electroencephalography; Ele

1993